SCHOTT Pharma AG & Co. KGaA (SHTPY)
4.37
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
SCHOTT Pharma Net Income (Quarterly) : 45.32M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 45.32M |
| March 31, 2026 | 36.43M |
| December 31, 2025 | 38.74M |
| September 30, 2025 | 39.35M |
| June 30, 2025 | 51.68M |
| March 31, 2025 | 40.30M |
| December 31, 2024 | 31.77M |
| Date | Value |
|---|---|
| September 30, 2024 | 37.56M |
| June 30, 2024 | 49.99M |
| March 31, 2024 | 27.35M |
| December 31, 2023 | 47.88M |
| September 30, 2023 | 37.76M |
| December 31, 2022 | 38.92M |
| September 30, 2022 | 25.82M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| West Pharmaceutical Services, Inc. | 154.00M |
| Drägerwerk AG & Co. KGaA | 33.65M |
| Sartorius AG | 107.78M |
| Reflect Scientific, Inc. | 0.0928M |
| Ottobock SE & Co. KGaA | 56.39M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 327.61M |
| Total Expenses (Quarterly) | 282.46M |
| EPS Diluted (Quarterly) | 0.0749 |
| Enterprise Value | 2.607B |
| Gross Profit Margin (Quarterly) | 30.66% |
| Profit Margin (Quarterly) | 13.83% |
| Earnings Yield | 6.05% |
| Operating Earnings Yield | 6.98% |
| Normalized Earnings Yield | 6.050 |